A human disease caused by the infection of parasitic worms SCHISTOSOMA HAEMATOBIUM. It is endemic in AFRICA and parts of the MIDDLE EAST. Tissue damages most often occur in the URINARY TRACT, specifically the URINARY BLADDER.
A family of the order DIPTERA with over 700 species. Important species that may be mechanical vectors of disease include Musca domesticus (HOUSEFLIES), Musca autumnalis (face fly), Stomoxys calcitrans (stable fly), Haematobia irritans (horn fly) and Fannia spp.
A species of trematode blood flukes of the family Schistosomatidae which occurs at different stages in development in veins of the pulmonary and hepatic system and finally the bladder lumen. This parasite causes urinary schistosomiasis.
Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States.
Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.
Infestations by PARASITES which live on, or burrow into, the surface of their host's EPIDERMIS. Most ectoparasites are ARTHROPODS.
An insect growth regulator which interferes with the formation of the insect cuticle. It is effective in the control of mosquitoes and flies.
Schistosomiasis caused by Schistosoma japonicum. It is endemic in the Far East and affects the bowel, liver, and spleen.
A species of trematode blood flukes of the family Schistosomatidae. It is common in the Nile delta. The intermediate host is the planorbid snail. This parasite causes schistosomiasis mansoni and intestinal bilharziasis.
An anthelmintic used in most schistosome and many cestode infestations.
A genus of trematode flukes belonging to the family Schistosomatidae. There are over a dozen species. These parasites are found in man and other mammals. Snails are the intermediate hosts.
Agents that act systemically to kill adult schistosomes.
Liver diseases caused by infections with PARASITES, such as tapeworms (CESTODA) and flukes (TREMATODA).
A species of trematode blood flukes belonging to the family Schistosomatidae whose distribution is confined to areas of the Far East. The intermediate host is a snail. It occurs in man and other mammals.
Determination of parasite eggs in feces.
Agents destructive to parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal.
A genus of planorbid freshwater snails, species of which are intermediate hosts of Schistosoma mansoni.
An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martindale, The Extra Pharmacopoeia, 31st ed, p121)
'Splenic diseases' refer to a range of medical conditions that affect the structure, function, or integrity of the spleen, leading to various symptoms and potential complications such as anemia, infection, or abdominal pain.
Any part or derivative of a helminth that elicits an immune reaction. The most commonly seen helminth antigens are those of the schistosomes.
Marine, freshwater, or terrestrial mollusks of the class Gastropoda. Most have an enclosing spiral shell, and several genera harbor parasites pathogenic to man.
Immunoglobulins produced in a response to HELMINTH ANTIGENS.
Agents destructive to snails and other mollusks.
A genus of small freshwater snails of the order Pulmonata, found throughout Africa and the Middle East, where it is a vector of SCHISTOSOMA HAEMATOBIUM.
Invertebrates or non-human vertebrates which transmit infective organisms from one host to another.
SCHISTOSOMIASIS of the brain, spinal cord, or meninges caused by infections with trematodes of the genus SCHISTOSOMA (primarily SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; and SCHISTOSOMA HAEMATOBIUM in humans). S. japonicum infections of the nervous system may cause an acute meningoencephalitis or a chronic encephalopathy. S. mansoni and S. haematobium nervous system infections are associated with acute transverse myelitis involving the lower portions of the spinal cord. (From Joynt, Clinical Neurology, 1998, Ch27, pp61-2)
The constant presence of diseases or infectious agents within a given geographic area or population group. It may also refer to the usual prevalence of a given disease with such area or group. It includes holoendemic and hyperendemic diseases. A holoendemic disease is one for which a high prevalent level of infection begins early in life and affects most of the child population, leading to a state of equilibrium such that the adult population shows evidence of the disease much less commonly than do children (malaria in many communities is a holoendemic disease). A hyperendemic disease is one that is constantly present at a high incidence and/or prevalence rate and affects all groups equally. (Last, A Dictionary of Epidemiology, 3d ed, p53, 78, 80)
A country in northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip, and the Red Sea north of Sudan, and includes the Asian Sinai Peninsula Its capital is Cairo.
Enlargement of the liver.
A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.
Infestation with parasitic worms of the helminth class.

Resolution and resurgence of schistosoma haematobium-induced pathology after community-based chemotherapy in ghana, as detected by ultrasound. (1/301)

Community-based treatment is recommended for endemic populations with urinary schistosomiasis; however, the optimal target group for treatment and retreatment interval have not been established. Using ultrasound, this study identified subpopulations whose lesions were most likely to respond to treatment and characterized resurgence of pathology. Ultrasound examination of 1202 infected patients was followed by chemotherapy with praziquantel. A sample of 698 patients was followed for 18 months after treatment. Nearly all types of bladder pathologies resolved after treatment, regardless of patient's age or intensity of initial infection. However, many patients' upper urinary tract pathologies (62.5%) did not resolve. During the 18-month follow-up period, reappearance of severe bladder pathologies was rare, and <10% of persons had resurgence of mild bladder pathologies. For this population, retreatment is not needed annually but might be cost effective if given several years later. Confirmation from other areas is required before general policies can be formed.  (+info)

Urinary schistosomiasis among schoolchildren in Ibadan, an urban community in south-western Nigeria. (2/301)

The current status of urinary schistosomiasis was assessed in Ibadan, an urban community in south-western Nigeria. Of 1331 children examined for eggs of S. haematobium in their urine, 17.4% were infected. Prevalence in postprimary schoolchildren was significantly (P < 0.01) higher (22.4%) than in primary schoolchildren (12.0%). Intensity of infection based on geometric mean egg count per 10 ml of urine was also higher in postprimary (36.7 eggs/10 ml urine) than primary pupils (29.9 eggs/10 ml urine). Boys had a significantly (P < 0.01) higher infection rate (24.1%) than girls (8.5%), and the intensity of infection was also higher (P < 0.01) in males (39.0 eggs/10 ml urine) than in females (22.1 eggs/10 ml urine). The overall geometric mean intensity of infection was highest (38.8 eggs/10 ml urine) in the 11-15 years age group. 42% of infected children excreted > 50 eggs/10 ml urine. 2.2% excreted S. mansoni eggs in urine. Water contact activities were more frequent (P < 0. 01) in males (31.8%) than females (38.2%). Nine species of snails were encountered, with B. (p) globosus being the the most abundant and widespread. These results show that urinary schistosomiasis is still being actively being transmitted in Ibadan.  (+info)

Emergence of Schistosoma mansoni infection in upper Egypt: the Giza governorate. (3/301)

We found an unexpectedly high prevalence of Schistosoma mansoni in a village in the Upper Egyptian governorate of Giza. Historically, S. mansoni is endemic in the northern Egyptian Nile Delta rather than in the southern Upper Egypt. This observation was made during an evaluation of a rural health care schistosomiasis surveillance program using a cross sectional survey for S. haematobium and S. mansoni in the village of El-Gezira El-Shakra El-Saf district in the Upper Egypt Giza Governorate. A 10% systematic random sample of households of the village was chosen. All persons in the selected houses were invited to submit urine and stool samples. All students from a primary school were also included in the study. Urine was screened by a polycarbonate filtration method and stool was examined using modified Kato-Katz technique. The prevalence of S. mansoni in the population sample and in the school children was 33.7% and 57.7%, respectively, whereas the prevalence of S. haematobium infection in the population sample and the school children was 7.4% and 10.6%, respectively. The prevalence of infection was highest in the younger age groups, and males were infected more than females. Review of Ministry of Health records showed that both species of vector snails, Bulinus truncatus and Biomphalaria alexandrina, were present from 1991 to 1995, and that B. alexandrina was more abundant than B. truncatus in the canals surrounding this village. The unexpected high prevalence of S. mansoni in this village indicates an urgent need to include training programs for S. mansoni surveillance in the primary health care facilities of Giza and to educate villagers to request examinations for S. mansoni as well as for S. haematobium infection.  (+info)

Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. (4/301)

Infants and children are routinely vaccinated with bacillus Calmette-Guerin (BCG) in areas of the world where worm infections are common. Because maternal helminth infection during pregnancy can sensitize the developing fetus, we studied whether this prenatal immunity persists in childhood and modifies the immune response to BCG. Children and newborns living in rural Kenya, where BCG is administered at birth and filariasis and schistosomiasis are endemic, were examined. T cells from 2- to 10-year-old children of mothers without filariasis or schistosomiasis produced 10-fold more IFN-gamma in response to mycobacterial purified protein derivative than children of helminth-infected mothers (p < 0.01). This relationship was restricted to purified protein derivative because maternal infection status did not correlate with filarial Ag-driven IL-2, IFN-gamma, IL-4, or IL-5 responses by children. Prospective studies initiated at birth showed that helminth-specific T cell immunity acquired in utero is maintained until at least 10-14 mo of age in the absence of infection with either Wuchereria bancrofti or Schistosoma haematobium. Purified protein derivative-driven T cell IFN-gamma production evaluated 10-14 mo after BCG vaccination was 26-fold higher for infants who were not sensitized to filariae or schistosomes in utero relative to subjects who experienced prenatal sensitization (p < 0.01). These data indicate that helminth-specific immune responses acquired during gestation persist into childhood and that this prenatal sensitization biases T cell immunity induced by BCG vaccination away from type 1 IFN-gamma responses associated with protection against mycobacterial infection.  (+info)

Parameters associated with Schistosoma haematobium infection before and after chemotherapy in school children from two villages in the coast province of Kenya. (5/301)

We evaluated the impact of praziquantel therapy (40 mg/kg body weight) on indicators of infection with Schistosoma haematobium by following a cohort of infected children from schools located 12 km apart in the Coast province of Kenya, at 0, 2, 4, 6, 12 and 18 months after treatment. Within this period, measurements of infection parameters pertaining to egg counts and haematuria (micro-, macro- and history) were evaluated at all time points. The initial prevalence of 100% dropped significantly 8 weeks after treatment with a similar trend in the intensity of infection. Microhaematuria followed the same trend as observed for egg counts while macrohaematuria remained low after treatment. Reinfection following successful therapy differed significantly between schools; in one school the children were reinfected immediately while those in the other remained uninfected despite similar starting prevalences, intensities of infection and cure rates. Transmission between the two areas looked homogeneous before treatment but when both groups were treated, contrasting transmission patterns became evident. In a regression model we evaluated factors that might be associated with reinfection, and after allowing for pretreatment infection level, age and sex, area (school) remained a highly significant predictor.  (+info)

Application of immunodiagnostic assays: detection of antibodies and circulating antigens in human schistosomiasis and correlation with clinical findings. (6/301)

In an initial cross-sectional survey, serum, urine, and stool samples were collected from 370 participants representing about 10% of the population (n = 4,438) in Behbeet village, 50 km south of Cairo, Egypt, an area well known to be endemic solely for Schistosoma haematobium. Diagnosis was approached in two parallel ways. The first approach, which simulated actual conditions in many endemic areas in Egypt, was based on physical examination and urine and stool microscopic analysis. The second approach was based on two advanced immunodiagnostic assay systems. One system detected antibodies to species-specific microsomal antigens, the other detected circulating schistosomal antigens. Microsomal antigens from S. haematobium and S. mansoni were used to detect antibodies in the Falcon assay screening test (FAST)-ELISA and the enzyme-linked immunoelectrotransfer blot (EITB). Circulating anodic antigen (CAA) and circulating cathodic antigen (CCA) were quantified in serum and urine samples in a sandwich ELISA using monoclonal antibodies. Parasitologically, the prevalence of S. haematobium was 7.01% in females and 25.82% in males, giving an overall prevalence of 15.8%. The combination of urine CCA and serum CAA for detecting circulating antigens and the combination of the S. haematobium adult worm microsomal antigens (HAMA) FAST-ELISA and the HAMA EITB for detecting antibodies significantly improved the sensitivity of detecting S. haematobium circulating antigens and antibodies. Also, including a medical examination as an integral part of field studies and correlating immunodiagnostic results with other clinical and investigational data allowed us to calculate an accurate estimation of S. haematobium prevalence in this area of low endemicity.  (+info)

Urine circulating soluble egg antigen in relation to egg counts, hematuria, and urinary tract pathology before and after treatment in children infected with Schistosoma haematobium in Kenya. (7/301)

A cohort of 117 school children infected with Schistosoma haematobium was followed-up after therapy with praziquantel (0, 2, 4, 6, 12, and 18 months) and various infection and morbidity parameters (egg counts, hematuria, soluble egg antigen [SEA] in urine, and ultrasonography-detectable pathology) were quantified. At the onset of the study, 97% of the children were positive for S. haematobium with a geometric mean egg count of 45.7 eggs/10 ml of urine. Eighty-one percent of the children were positive for SEA in urine with a geometric mean SEA concentration of 218.8 ng/ml of urine. Ninety-two percent and 56% of the children were microhematuria positive and macrohematuria positive, respectively. Two months after treatment, all infection and morbidity indicators had significantly decreased. Reinfection after treatment as determined by detection of eggs in urine was observed by four months post-treatment while the other parameters remained low. The clearance of SEA was slower than that of egg counts while pathology resolved at an even slower pace. Levels of SEA and egg output showed similar correlations with ultrasound detectable pathology; these correlations were better than the correlation between hematuria and pathology.  (+info)

Immunochemical characterization and diagnostic potential of a 63-kilodalton Schistosoma antigen. (8/301)

Schistosoma circulating antigens were used for the detection of active infection. Anti-S. mansoni IgG2a monoclonal antibody (MAb) designated C5C4 was generated. The target epitope of this MAb was detected in adult worms, eggs, and cercariae antigenic extracts of S. mansoni and S. haematobium, had a molecular size of 63 kD, and was not detected in Fasciola hepatica and Ascaris. In addition, a 50-kD degradation product was identified only in the urine of infected individuals. Analysis by high-performance liquid chromatography of the purified antigen demonstrated only one peak. The 63-kD antigen was characterized as a protein containing 40.4% hydrophobic, 7.5% acidic, and 8.8% basic amino acids. The C5C4 MAb was used in a Fast Dot-ELISA for rapid and simple diagnosis of human schistosomiasis. The 63-kD circulating antigen was detected in 92% of urine samples from 330 S. mansoni-infected individuals, with 16% false-positive results among 130 noninfected individuals.  (+info)

I'm sorry for any confusion, but "Schistosomiasis haematobia" is not a recognized medical term. Schistosomiasis is a parasitic disease caused by several species of blood flukes (schistosomes). The two main forms that affect humans are Schistosoma mansoni and Schistosoma haematobium, but the term "haematobia" itself refers to the presence of blood in urine.

So, when we talk about Schistosoma haematobium, it's a specific species of schistosome that causes an infection known as urogenital schistosomiasis, which is characterized by the presence of blood in the urine (haematuria) and other symptoms.

If you have any questions about tropical diseases or parasitic infections, feel free to ask!

I apologize for any confusion, but "Muscidae" is not a medical term. It is a taxonomic family of flies, also known as houseflies or muscoid flies. The Muscidae family includes over 4,000 species, some of which can be found in various environments, including human dwellings and agricultural settings. Some members of this family are considered pests due to their habits of feeding on decaying organic matter, transmitting diseases, or contaminating food sources.

"Schistosoma haematobium" is a species of parasitic flatworm, also known as a blood fluke, that causes the disease schistosomiasis (also known as bilharzia). This specific species is the most common cause of urogenital schistosomiasis.

The life cycle of Schistosoma haematobium involves freshwater snails as intermediate hosts. The parasite's eggs are released in the urine of an infected person and hatch in fresh water, releasing miracidia that infect the snail. After several developmental stages, the parasites emerge from the snail as free-swimming cercariae, which then infect the human host by penetrating the skin during contact with infested water.

Once inside the human body, the cercariae transform into schistosomula and migrate to the venous plexus around the bladder, where they mature into adult worms. The female worms lay eggs that can cause inflammation and damage to the urinary tract and, in some cases, other organs. Symptoms of infection can include blood in the urine, frequent urination, and pain during urination. Chronic infection can lead to more serious complications, such as bladder cancer and kidney damage.

Schistosomiasis, also known as bilharzia or snail fever, is a parasitic infection caused by several species of the trematode flatworm Schistosoma. The infection occurs when people come into contact with freshwater contaminated with the parasite's larvae, which are released by infected freshwater snails.

The larvae penetrate the skin, enter the bloodstream, and mature into adult worms in the blood vessels of the urinary tract or intestines. The female worms lay eggs, which can cause inflammation and scarring in various organs, including the liver, lungs, and brain.

Symptoms of schistosomiasis may include fever, chills, cough, muscle aches, and diarrhea. In chronic cases, the infection can lead to serious complications such as kidney damage, bladder cancer, and seizures. Schistosomiasis is prevalent in tropical and subtropical regions with poor sanitation and lack of access to safe drinking water. It is preventable through improved water supply, sanitation, and snail control measures. Treatment typically involves the use of a medication called praziquantel, which kills the adult worms.

Schistosomiasis mansoni is a parasitic infection caused by the trematode flatworm Schistosoma mansoni. The disease cycle begins when human hosts come into contact with fresh water contaminated with the parasite's larvae, called cercariae, which are released from infected snail intermediate hosts.

Once the cercariae penetrate the skin of a human host, they transform into schistosomula and migrate through various tissues before reaching the hepatic portal system. Here, the parasites mature into adult worms, mate, and produce eggs that can cause inflammation and damage to the intestinal wall, liver, spleen, and other organs.

Symptoms of schistosomiasis mansoni may include fever, chills, cough, diarrhea, abdominal pain, and blood in stool or urine. Chronic infection can lead to severe complications such as fibrosis of the liver, kidney damage, bladder cancer, and neurological disorders.

Preventive measures include avoiding contact with contaminated water sources, proper sanitation, and access to safe drinking water. Treatment typically involves administering a single dose of the drug praziquantel, which is effective in eliminating the adult worms and reducing egg production. However, it does not prevent reinfection.

Ectoparasitic infestations refer to the invasion and multiplication of parasites, such as lice, fleas, ticks, or mites, on the outer surface of a host organism, typically causing irritation, itching, and other skin disorders. These parasites survive by feeding on the host's blood, skin cells, or other bodily substances, leading to various health issues if left untreated.

Ectoparasitic infestations can occur in humans as well as animals and may require medical intervention for proper diagnosis and treatment. Common symptoms include redness, rash, inflammation, and secondary bacterial or viral infections due to excessive scratching. Preventive measures such as personal hygiene, regular inspections, and avoiding contact with infested individuals or environments can help reduce the risk of ectoparasitic infestations.

Diflubenzuron is an insect growth regulator that belongs to the benzoylphenyl urea class. It works by inhibiting the synthesis of chitin, a crucial component of the exoskeleton of insects, which results in the prevention of their normal molting and growth. Diflubenzuron is used primarily for pest control in agriculture, forestry, and vector management (such as controlling mosquito populations). It's important to note that this compound is not typically used in human medicine.

Schistosomiasis japonica is a specific form of schistosomiasis, which is also known as snail fever. It is caused by the parasitic flatworm Schistosoma japonicum. This disease is prevalent in East Asian countries like China, Indonesia, and the Philippines.

The life cycle of Schistosoma japonicum involves freshwater-dwelling snails as an intermediate host. Humans get infected through direct contact with contaminated water, where the parasite's larvae are released from the snails. The larvae penetrate the skin, enter the bloodstream, and migrate to the liver. Here, they mature into adult worms and start producing eggs, which are excreted through feces or urine.

The symptoms of Schistosomiasis japonica can vary depending on the stage and severity of the infection. In the early stages, individuals might experience skin rashes, fever, chills, and muscle aches. As the parasite eggs travel through the body, they can cause inflammation and damage to various organs, including the liver, intestines, and lungs. Chronic infections can lead to severe complications such as fibrosis, scarring, and increased risk of bladder cancer.

Preventive measures include avoiding contact with contaminated water sources, proper sanitation, and snail control. Treatment typically involves administering the drug praziquantel, which is effective against Schistosoma japonicum and other schistosome species.

"Schistosoma mansoni" is a specific species of parasitic flatworm, also known as a blood fluke, that causes the disease schistosomiasis (also known as snail fever). This trematode has a complex life cycle involving both freshwater snails and humans. The adult worms live in the blood vessels of the human host, particularly in the venous plexus of the intestines, where they lay eggs that are excreted through feces. These eggs can hatch in fresh water and infect specific snail species, which then release a free-swimming form called cercariae. These cercariae can penetrate the skin of humans who come into contact with infested water, leading to infection and subsequent health complications if left untreated.

The medical definition of "Schistosoma mansoni" is: A species of trematode parasitic flatworm that causes schistosomiasis in humans through its complex life cycle involving freshwater snails as an intermediate host. Adult worms reside in the blood vessels of the human host, particularly those surrounding the intestines, and release eggs that are excreted through feces. Infection occurs when cercariae, released by infected snails, penetrate human skin during contact with infested water.

Praziquantel is an anthelmintic medication, which is used to treat and prevent trematode (fluke) infections, including schistosomiasis (also known as bilharzia or snail fever), clonorchiasis, opisthorchiasis, paragonimiasis, and fasciolopsiasis. It works by causing severe spasms in the muscle cells of the parasites, ultimately leading to their death. Praziquantel is available in tablet form and is typically taken orally in a single dose, although the dosage may vary depending on the type and severity of the infection being treated.

It's important to note that praziquantel is not effective against tapeworm infections, and other medications such as niclosamide or albendazole are used instead for those infections. Also, Praziquantel should be taken under medical supervision, as it may have some side effects, including abdominal pain, nausea, vomiting, dizziness, and headache.

It's important to consult a healthcare professional before taking any medication.

Schistosoma is a genus of flatworms that cause the disease schistosomiasis, also known as snail fever. These parasitic worms infect freshwater snails and then release a form of the parasite that can penetrate the skin of humans when they come into contact with contaminated water. The larvae mature into adult worms in the human body, living in the blood vessels of the bladder, intestines or other organs, where they lay eggs. These eggs can cause serious damage to internal organs and lead to a range of symptoms including fever, chills, diarrhea, and anemia. Schistosomiasis is a significant public health problem in many tropical and subtropical regions around the world.

Schistosomicides are medications specifically used to treat Schistosomiasis, also known as snail fever or bilharzia. This is a parasitic disease caused by several species of flatworms belonging to the genus Schistosoma. The drugs that act against these parasites are called schistosomicides.

The most common schistosomicides include:

1. Praziquantel: This is the first-line treatment for all forms of Schistosomiasis. It works by causing paralysis of the worms, which then detach from the host's tissues and are swept out of the body.

2. Oxamniquine (Mansil): Primarily used to treat infections caused by Schistosoma mansoni. It works by causing the worms to lose their grip on the blood vessels, leading to their death and elimination from the body.

3. Triclabendazole: Used for the treatment of liver fluke infections, but it has also shown efficacy against some Schistosoma species, particularly Schistosoma haematobium and Schistosoma japonicum.

It is important to note that while these medications are effective at killing the adult worms, they do not prevent reinfection. Therefore, measures should be taken to avoid contact with contaminated water where the parasites are present.

Parasitic liver diseases refer to conditions caused by protozoa or helminths (parasitic worms) that infect and damage the liver. These parasites can enter the body through contaminated food, water, or direct contact with an infected host. Some examples of parasitic liver diseases include:

1. Ascariasis: Caused by the roundworm Ascaris lumbricoides, which can infect the liver and bile ducts, leading to inflammation, obstruction, and abscess formation.
2. Echinococcosis (Hydatid disease): A rare but serious condition caused by the larval stage of tapeworms from the genus Echinococcus. The liver is the most commonly affected organ, with cysts forming in the liver parenchyma that can grow slowly over several years and cause complications such as rupture or secondary bacterial infection.
3. Fascioliasis: A foodborne trematode (fluke) infection caused by Fasciola hepatica or Fasciola gigantica, which affects the liver and bile ducts. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
4. Leishmaniasis: A protozoan infection caused by Leishmania spp., which can affect various organs, including the liver. Visceral leishmaniasis (kala-azar) is the most severe form of the disease, characterized by hepatosplenomegaly, fever, and anemia.
5. Toxoplasmosis: A protozoan infection caused by Toxoplasma gondii, which can affect the liver and other organs. While most immunocompetent individuals remain asymptomatic or experience mild flu-like symptoms, immunocompromised patients are at risk of severe liver damage and disseminated disease.
6. Schistosomiasis: A trematode (fluke) infection caused by Schistosoma spp., which affects the liver and portal venous system. The parasites lay eggs in the liver, causing granulomatous inflammation, fibrosis, and portal hypertension.
7. Fasciolopsiasis: A trematode (fluke) infection caused by Fasciolopsis buski, which affects the small intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
8. Paragonimiasis: A trematode (lung fluke) infection caused by Paragonimus spp., which can affect the lungs, brain, and other organs, including the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
9. Clonorchiasis: A trematode (liver fluke) infection caused by Clonorchis sinensis, which affects the bile ducts and liver. The parasites lay eggs in the bile ducts, causing inflammation, cholangitis, and cholangiocarcinoma.
10. Opisthorchiasis: A trematode (liver fluke) infection caused by Opisthorchis spp., which affects the bile ducts and liver. The parasites lay eggs in the bile ducts, causing inflammation, cholangitis, and cholangiocarcinoma.
11. Heterophyiasis: A trematode (intestinal fluke) infection caused by Heterophyes spp., which affects the small intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
12. Metagonimiasis: A trematode (intestinal fluke) infection caused by Metagonimus spp., which affects the small intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
13. Echinostomiasis: A trematode (intestinal fluke) infection caused by Echinostoma spp., which affects the small intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
14. Gastrodiscoidiasis: A trematode (intestinal fluke) infection caused by Gastrodiscoides spp., which affects the large intestine and liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
15. Fascioliasis: A trematode (liver fluke) infection caused by Fasciola spp., which affects the liver and bile ducts. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
16. Paragonimiasis: A trematode (lung fluke) infection caused by Paragonimus spp., which affects the lungs and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
17. Schistosomiasis: A trematode (blood fluke) infection caused by Schistosoma spp., which affects the blood vessels and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
18. Clonorchiasis: A trematode (liver fluke) infection caused by Clonorchis sinensis, which affects the liver and bile ducts. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
19. Opisthorchiasis: A trematode (liver fluke) infection caused by Opisthorchis spp., which affects the liver and bile ducts. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
20. Metagonimiasis: A trematode (intestinal fluke) infection caused by Metagonimus spp., which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
21. Heterophyesiasis: A trematode (intestinal fluke) infection caused by Heterophyes spp., which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
22. Echinostomiasis: A trematode (intestinal fluke) infection caused by Echinostoma spp., which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
23. Fasciolopsiasis: A trematode (intestinal fluke) infection caused by Fasciolopsis buski, which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
24. Paragonimiasis: A trematode (lung fluke) infection caused by Paragonimus spp., which affects the lungs and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
25. Spirometra mansoni: A trematode (tapeworm) infection caused by Spirometra mansoni, which affects the brain and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
26. Taenia solium: A trematode (tapeworm) infection caused by Taenia solium, which affects the brain and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
27. Hymenolepis nana: A trematode (tapeworm) infection caused by Hymenolepis nana, which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
28. Diphyllobothrium latum: A trematode (tapeworm) infection caused by Diphyllobothrium latum, which affects the small intestine and sometimes the liver. The larvae migrate through the liver tissue, causing inflammation, necrosis, and fibrosis.
29. Echinococcus granulosus:

"Schistosoma japonicum" is a species of parasitic flatworms (trematodes) that causes schistosomiasis, also known as snail fever, in humans. This disease is prevalent in East Asian countries such as China, Indonesia, and the Philippines.

The life cycle of Schistosoma japonicum involves freshwater snails as intermediate hosts. The parasites lay eggs in the blood vessels of the human host, which then pass through the body and are excreted into water. When the eggs hatch, they release miracidia that infect specific species of freshwater snails. After several developmental stages within the snail, the parasite releases cercariae, which can infect humans by penetrating the skin during contact with infested water.

Once inside the human host, the cercariae transform into schistosomula and migrate to the lungs, then to the liver, where they mature into adult worms. The adult worms pair up, mate, and produce eggs that can cause inflammation, granulomas, and fibrosis in various organs, depending on their location.

Schistosoma japonicum is responsible for significant morbidity and mortality in endemic areas, with symptoms ranging from fever, rash, and diarrhea to more severe complications such as liver damage, bladder cancer, and kidney failure. Preventive measures include avoiding contact with infested water, treating infected individuals, and improving sanitation and hygiene practices.

A "Parasite Egg Count" is a laboratory measurement used to estimate the number of parasitic eggs present in a fecal sample. It is commonly used in veterinary and human medicine to diagnose and monitor parasitic infections, such as those caused by roundworms, hookworms, tapeworms, and other intestinal helminths (parasitic worms).

The most common method for measuring parasite egg counts is the McMaster technique. This involves mixing a known volume of feces with a flotation solution, which causes the eggs to float to the top of the mixture. A small sample of this mixture is then placed on a special counting chamber and examined under a microscope. The number of eggs present in the sample is then multiplied by a dilution factor to estimate the total number of eggs per gram (EPG) of feces.

Parasite egg counts can provide valuable information about the severity of an infection, as well as the effectiveness of treatment. However, it is important to note that not all parasitic infections produce visible eggs in the feces, and some parasites may only shed eggs intermittently. Therefore, a negative egg count does not always rule out the presence of a parasitic infection.

Anthelmintics are a type of medication used to treat infections caused by parasitic worms, also known as helminths. These medications work by either stunting the growth of the worms, paralyzing them, or killing them outright, allowing the body to expel the worms through normal bodily functions. Anthelmintics are commonly used to treat infections caused by roundworms, tapeworms, flukeworms, and hookworms. Examples of anthelmintic drugs include albendazole, mebendazole, praziquantel, and ivermectin.

'Biomphalaria' is a genus of freshwater snails that are intermediate hosts for the parasitic flatworms that cause schistosomiasis, also known as snail fever. This is a type of trematode infection that affects humans and other animals. The snails of the 'Biomphalaria' genus are native to Africa and parts of South America and play an essential role in the life cycle of the parasitic worms that cause this disease.

Schistosomiasis is a significant public health issue, particularly in developing countries with poor sanitation and hygiene. The World Health Organization (WHO) estimates that more than 200 million people worldwide are infected with schistosomes, resulting in tens of thousands of deaths each year. Effective control of the disease requires a multi-faceted approach, including the prevention of transmission through snail control and the treatment of infected individuals with praziquantel, the drug of choice for schistosomiasis.

Oxamniquine is an antiparasitic medication used to treat infections caused by certain types of intestinal worms, specifically the parasite called *Strongyloides stercoralis*. It works by inhibiting the motility and reproduction of the parasites, leading to their eventual elimination from the body.

It is important to note that oxamniquine is not commonly used in clinical practice due to the availability of other effective antiparasitic agents and its potential for causing adverse effects such as nausea, vomiting, dizziness, and headache. Additionally, it should only be administered under the supervision of a healthcare professional and according to approved guidelines, as improper use can lead to treatment failure or the development of drug-resistant parasites.

Splenic diseases refer to a range of medical conditions that affect the structure, function, or health of the spleen. The spleen is an organ located in the upper left quadrant of the abdomen, which plays a vital role in filtering the blood and fighting infections. Some common splenic diseases include:

1. Splenomegaly: Enlargement of the spleen due to various causes such as infections, liver disease, blood disorders, or cancer.
2. Hypersplenism: Overactivity of the spleen leading to excessive removal of blood cells from circulation, causing anemia, leukopenia, or thrombocytopenia.
3. Splenic infarction: Partial or complete blockage of the splenic artery or its branches, resulting in tissue death and potential organ dysfunction.
4. Splenic rupture: Traumatic or spontaneous tearing of the spleen capsule, causing internal bleeding and potentially life-threatening conditions.
5. Infections: Bacterial (e.g., sepsis, tuberculosis), viral (e.g., mononucleosis, cytomegalovirus), fungal (e.g., histoplasmosis), or parasitic (e.g., malaria) infections can affect the spleen and cause various symptoms.
6. Hematologic disorders: Conditions such as sickle cell disease, thalassemia, hemolytic anemias, lymphomas, leukemias, or myeloproliferative neoplasms can involve the spleen and lead to its enlargement or dysfunction.
7. Autoimmune diseases: Conditions like rheumatoid arthritis, systemic lupus erythematosus, or vasculitis can affect the spleen and cause various symptoms.
8. Cancers: Primary (e.g., splenic tumors) or secondary (e.g., metastatic cancer from other organs) malignancies can involve the spleen and lead to its enlargement, dysfunction, or rupture.
9. Vascular abnormalities: Conditions such as portal hypertension, Budd-Chiari syndrome, or splenic vein thrombosis can affect the spleen and cause various symptoms.
10. Trauma: Accidental or intentional injuries to the spleen can lead to bleeding, infection, or organ dysfunction.

Helminth antigens refer to the proteins or other molecules found on the surface or within helminth parasites that can stimulate an immune response in a host organism. Helminths are large, multicellular parasitic worms that can infect various tissues and organs in humans and animals, causing diseases such as schistosomiasis, lymphatic filariasis, and soil-transmitted helminthiases.

Helminth antigens can be recognized by the host's immune system as foreign invaders, leading to the activation of various immune cells and the production of antibodies. However, many helminths have evolved mechanisms to evade or suppress the host's immune response, allowing them to establish long-term infections.

Studying helminth antigens is important for understanding the immunology of helminth infections and developing new strategies for diagnosis, treatment, and prevention. Some researchers have also explored the potential therapeutic use of helminth antigens or whole helminths as a way to modulate the immune system and treat autoimmune diseases or allergies. However, more research is needed to determine the safety and efficacy of these approaches.

I'm sorry for any confusion, but the term "snails" is not a medical term. It is a common name used to refer to a large group of land and sea-dwelling mollusks that have coiled shells and move slowly by means of a muscular foot. If you have any questions about medical terminology or health-related topics, I'd be happy to help! Just let me know what you're looking for.

Antibodies are proteins produced by the immune system in response to the presence of a foreign substance, known as an antigen. They are capable of recognizing and binding to specific antigens, neutralizing or marking them for destruction by other immune cells.

Helminths are parasitic worms that can infect humans and animals. They include roundworms, tapeworms, and flukes, among others. Helminth infections can cause a range of symptoms, depending on the type of worm and the location of the infection.

Antibodies to helminths are produced by the immune system in response to an infection with one of these parasitic worms. These antibodies can be detected in the blood and serve as evidence of a current or past infection. They may also play a role in protecting against future infections with the same type of worm.

There are several different classes of antibodies, including IgA, IgD, IgE, IgG, and IgM. Antibodies to helminths are typically of the IgE class, which are associated with allergic reactions and the defense against parasites. IgE antibodies can bind to mast cells and basophils, triggering the release of histamine and other inflammatory mediators that help to protect against the worm.

In addition to IgE, other classes of antibodies may also be produced in response to a helminth infection. For example, IgG antibodies may be produced later in the course of the infection and can provide long-term immunity to reinfection. IgA antibodies may also be produced and can help to prevent the attachment and entry of the worm into the body.

Overall, the production of antibodies to helminths is an important part of the immune response to these parasitic worms. However, in some cases, the presence of these antibodies may also be associated with allergic reactions or other immunological disorders.

Molluscicides are a type of pesticide specifically designed to kill mollusks, which include snails and slugs. These substances work by interfering with the mollusk's nervous system, leading to paralysis and death. Molluscicides are often used in agricultural settings to protect crops from damage caused by these pests, but they can also be found in residential products designed to control nuisance snails and slugs in gardens or landscaping.

It is important to note that molluscicides can be harmful to other organisms as well, including pets and wildlife, so they should be used with caution and according to the manufacturer's instructions. Additionally, some molluscicides may pose risks to human health if not handled properly, so it is essential to follow safety guidelines when using these products.

'Bulinus' is a genus of freshwater snails that have a spiral, coiled shell. These snails are aquatic pulmonate gastropod mollusks, which means they breathe air but live in water. They are often found in tropical and subtropical regions of Africa and the Middle East.

Bulinus snails are known to be intermediate hosts for several species of parasitic flatworms that cause schistosomiasis (also known as bilharzia), a chronic and debilitating disease that affects millions of people worldwide, particularly in developing countries with poor sanitation and access to safe water.

The most common species of Bulinus snails involved in the transmission of schistosomiasis are Bulinus truncatus and Bulinus globosus. These snails ingest the larval stage of the parasitic flatworms, which then develop into a different larval stage inside the snail's tissues. When an infected snail releases its faeces into the water, the larval flatworms are released and can infect humans who come into contact with the contaminated water.

Therefore, Bulinus snails play a crucial role in the life cycle of these parasites and are an important public health concern in areas where schistosomiasis is endemic.

A disease vector is a living organism that transmits infectious pathogens from one host to another. These vectors can include mosquitoes, ticks, fleas, and other arthropods that carry viruses, bacteria, parasites, or other disease-causing agents. The vector becomes infected with the pathogen after biting an infected host, and then transmits the infection to another host through its saliva or feces during a subsequent blood meal.

Disease vectors are of particular concern in public health because they can spread diseases rapidly and efficiently, often over large geographic areas. Controlling vector-borne diseases requires a multifaceted approach that includes reducing vector populations, preventing bites, and developing vaccines or treatments for the associated diseases.

Neuroschistosomiasis is a form of schistosomiasis, which is a parasitic infection caused by Schistosoma species. It is characterized by the invasion and inflammation of the central nervous system (CNS) by the parasite's eggs or larvae. This can lead to various neurological symptoms such as seizures, headaches, visual disturbances, and motor or sensory deficits. Neuroschistosomiasis is a serious and potentially life-threatening condition that requires prompt diagnosis and treatment.

The two Schistosoma species most commonly associated with neuroschistosomiasis are S. japonicum and S. mansoni. The parasites typically enter the human body through skin contact with contaminated water, where they mature into adult worms in the bloodstream. Female worms then lay eggs, some of which may be carried to the CNS by the circulatory system.

Neuroschistosomiasis can occur in both acute and chronic forms. Acute neuroschistosomiasis is characterized by an inflammatory response to the parasite's eggs or larvae, which can cause eosinophilic meningitis or encephalitis. Chronic neuroschistosomiasis may result in the formation of granulomas around the eggs, leading to various neurological symptoms depending on the location and extent of the damage.

Diagnosis of neuroschistosomiasis typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT scans), and laboratory tests (such as serology or CSF analysis). Treatment usually consists of anti-parasitic drugs such as praziquantel, combined with corticosteroids to manage the inflammatory response. In severe cases, surgical intervention may be necessary to alleviate symptoms or prevent further damage.

An endemic disease is a type of disease that is regularly found among particular people or in a certain population, and is spread easily from person to person. The rate of infection is consistently high in these populations, but it is relatively stable and does not change dramatically over time. Endemic diseases are contrasted with epidemic diseases, which suddenly increase in incidence and spread rapidly through a large population.

Endemic diseases are often associated with poverty, poor sanitation, and limited access to healthcare. They can also be influenced by environmental factors such as climate, water quality, and exposure to vectors like mosquitoes or ticks. Examples of endemic diseases include malaria in some tropical countries, tuberculosis (TB) in many parts of the world, and HIV/AIDS in certain populations.

Effective prevention and control measures for endemic diseases typically involve improving access to healthcare, promoting good hygiene and sanitation practices, providing vaccinations when available, and implementing vector control strategies. By addressing the underlying social and environmental factors that contribute to the spread of these diseases, it is possible to reduce their impact on affected populations and improve overall health outcomes.

I am not aware of any medical definition for the term "Egypt." Egypt is a country located in the northeastern corner of Africa, known for its rich history and cultural heritage. It is home to various ancient artifacts and monuments, including the Pyramids of Giza and the Sphinx.

If you have any specific medical or health-related questions related to Egypt, such as information about diseases prevalent in the country or healthcare practices there, I would be happy to try to help answer those for you.

Hepatomegaly is a medical term that refers to an enlargement of the liver beyond its normal size. The liver is usually located in the upper right quadrant of the abdomen and can be felt during a physical examination. A healthcare provider may detect hepatomegaly by palpating (examining through touch) the abdomen, noticing that the edge of the liver extends past the lower ribcage.

There are several possible causes for hepatomegaly, including:
- Fatty liver disease (both alcoholic and nonalcoholic)
- Hepatitis (viral or autoimmune)
- Liver cirrhosis
- Cancer (such as primary liver cancer, metastatic cancer, or lymphoma)
- Infections (e.g., bacterial, fungal, or parasitic)
- Heart failure and other cardiovascular conditions
- Genetic disorders (e.g., Gaucher's disease, Niemann-Pick disease, or Hunter syndrome)
- Metabolic disorders (e.g., glycogen storage diseases, hemochromatosis, or Wilson's disease)

Diagnosing the underlying cause of hepatomegaly typically involves a combination of medical history, physical examination, laboratory tests, and imaging studies like ultrasound, CT scan, or MRI. Treatment depends on the specific cause identified and may include medications, lifestyle changes, or, in some cases, surgical intervention.

A granuloma is a small, nodular inflammatory lesion that occurs in various tissues in response to chronic infection, foreign body reaction, or autoimmune conditions. Histologically, it is characterized by the presence of epithelioid macrophages, which are specialized immune cells with enlarged nuclei and abundant cytoplasm, often arranged in a palisading pattern around a central area containing necrotic debris, microorganisms, or foreign material.

Granulomas can be found in various medical conditions such as tuberculosis, sarcoidosis, fungal infections, and certain autoimmune disorders like Crohn's disease. The formation of granulomas is a complex process involving both innate and adaptive immune responses, which aim to contain and eliminate the offending agent while minimizing tissue damage.

Helminthiasis is a medical condition characterized by the infection and infestation of body tissues and organs by helminths, which are parasitic worms. These worms can be classified into three main groups: nematodes (roundworms), cestodes (tapeworms), and trematodes (flukes).

Helminthiasis infections can occur through various modes of transmission, such as ingestion of contaminated food or water, skin contact with contaminated soil, or direct contact with an infected person or animal. The severity of the infection depends on several factors, including the type and number of worms involved, the duration of the infestation, and the overall health status of the host.

Common symptoms of helminthiasis include abdominal pain, diarrhea, nausea, vomiting, weight loss, anemia, and nutritional deficiencies. In severe cases, the infection can lead to organ damage or failure, impaired growth and development in children, and even death.

Diagnosis of helminthiasis typically involves microscopic examination of stool samples to identify the presence and type of worms. Treatment usually consists of administering anthelmintic drugs that are effective against specific types of worms. Preventive measures include improving sanitation and hygiene, avoiding contact with contaminated soil or water, and practicing safe food handling and preparation.

No FAQ available that match "schistosomiasis haematobia"

No images available that match "schistosomiasis haematobia"